LONDON (Alliance News) - Hikma Pharmaceuticals PLC Thursday said Chairman Said Darwazah exercised options over 75,924 shares at no cost under a company share plan Thursday.
Following this transaction, Darwazah has a total holding of 11 million shares, which represents 5.51% stake in the firm.
Shares in the pharmaceutical company were trading 1.1% higher at 1,702.00 pence Thursday morning.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.